Company anticipates initial human trials to focus on AML upon IND clearance SOUTH SAN FRANCISCO, Calif., July...
Company anticipates near term filing of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO...
Company continuing IND-enabling activities in preparation for submission of Investigational New Drug...
SOUTH SAN FRANCISCO, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq:CERO...
SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc...
CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) ("CERo") an innovative immunotherapy company seeking to advance the next generation of engineered...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.